ClinicalTrials.gg
CompletedNCT02761096Updated Feb 28, 2019

Effect of Acupuncture on Inflammation and Immune Function After Craniotomy

An interventional study of acupuncture and conventional treatment in Unruptured Cerebral Aneurysm, Hemifacial Spasm and Brain Tumor, sponsored by Kyunghee University Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-28.

Sponsored by Kyunghee University Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to evaluate the effect of acupuncture on inflammation and immune function after craniotomy. This study will be a single-center, parallel group clinical trial that will be conducted at Kyung Hee University Hospital at Gangdong, Seoul, Korea.

Read the detailed description

For Study group, The intervention will start no more than 48 hours after craniotomy and will be given once a day for 6 days (a total of 6 sessions within 8 days). Acupuncture, electroacupuncture, and intradermal acupuncture will be performed at every session.

For Control group, The subjects in the control group will only receive conventional treatment.

02

Conditions studied

  • Unruptured Cerebral Aneurysm
  • Hemifacial Spasm
  • Brain Tumor
03

In context

Hemifacial Spasm

23 studies on the registry are indexed under Hemifacial Spasm; 3 are open to participants now.

This study's enrollment of 44 is below the median of 61 across 11 interventional studies indexed under Hemifacial Spasm.

Browse Hemifacial Spasm studies →

Lead sponsor

Kyunghee University Medical Center is the lead sponsor of 63 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants must meet all of the following criteria in order to be included:

  1. planning to undergo regular craniotomy performed for an unruptured aneurysm, facial spasm, or brain tumor;
  2. age > 18 years;
  3. acupuncture treatment that can start within 48 h after craniotomy;
  4. voluntary participation and provision of signed form.

Exclusion criteria

Exclusion Criteria:

Participants with any of the following conditions will be excluded:

  1. serum C-reactive protein (CRP) level ≥ 1.0 mg/dl before craniotomy;
  2. a condition other than an unruptured aneurysm, facial spasm, or brain tumor as an indication for craniotomy;
  3. craniotomy performed for infectious brain diseases such as brain abscess or subdural empyema;
  4. medication use that can affect the immune system or white blood cell (WBC) count, such as drugs, , or anticancer drugs or use of these medications within one month prior to the craniotomy;
  5. a history of surgery at the same site;
  6. emergency surgery; or
  7. a severe medical disease, e.g. congestive heart failure, chronic renal failure.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Study group

    The acupuncture intervention will start no more than 48 hours after craniotomy and will be given once a day for 6 days (a total of 6 sessions within 8 days). It will be given in addition to conventional treatments. All interventions will be performed by one Korean Medicine doctor with over 5 years of working experience with a college education of 6 years. This doctor will be trained in the study protocol before the start of the trial.

    Device: acupuncture · Other: conventional treatment

  • Other
    Control group

    The subjects in the control group will only receive conventional treatment. This involves general management after craniotomy in the department of neurosurgery.

    Other: conventional treatment

Interventions

  • Deviceacupuncture

    Acupuncture, electroacupuncture, and intradermal acupuncture will be performed at every session. Sterile disposable stainless steel acupuncture needles (0.25 mm × 30 mm) will be used. Acupuncture needles will be inserted bilaterally at the following acupuncture points: LI4, LI11, PC6, ST36, GB39 and LR3, and GV20. If GV20 is close to the surgical site, this acupoint may be excluded. An electric stimulator will be connected to the handle of each needle at LI4, LI11, ST36, and LR3 and a current of 5 Hz will be applied. After the needles are removed, intradermal acupuncture needles with tape (DB130A; 0.25 mm × 1.5mm) will be inserted at the same acupoints (LI4, LI11, PC6, ST36, GB39, and LR3 bilaterally, and GV20) and left in place until the next session.

  • Otherconventional treatment

    The subjects in the control group will only receive conventional treatment. This involves general management after craniotomy in the department of neurosurgery and includes stabilizing vital signs, pain control, prevention and treatment of infections, and other IV fluid or drug therapy required based on the condition of the patient.

06

What researchers measure

Primary outcomes

  1. Serum CRP

    Turbidimetric immunoassay will be performed for measurement of CRP. A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast.

    Time frame: 2 days after surgery

Secondary outcomes

  1. Serum CRP

    Turbidimetric immunoassay will be performed for measurement of CRP. A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast.

    Time frame: within 48 h before the surgery, 4 days after surgery and 7 days after surgery

  2. Serum erythrocyte sedimentation rate (ESR)

    The photometrical capillary method will be performed for measurement of ESR. A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast.

    Time frame: within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery

  3. Serum TNF-α

    Enzyme-linked immunosorbent assay (ELISA) will be performed for measurement A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast.

    Time frame: within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery

  4. Serum IL-1β

    Enzyme-linked immunosorbent assay (ELISA) will be performed for measurement A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast.

    Time frame: within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery

  5. Serum IL-6

    Enzyme-linked immunosorbent assay (ELISA) will be performed for measurement A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast.

    Time frame: within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery

  6. fever

    Any fever with a body temperature over 38℃ will be recorded on the case report form.

    Time frame: During the post operation day to 7 days after operation day. Body temperature will be measured at 6:00, 10:00, 18:00, and 22:00 every day.

  7. use of additional antibiotics

    Use of additional antibiotics will be recorded on the case report form.

    Time frame: During the post operation day to 7 days after operation day

  8. infection sign

    Infections such as pneumonia or urinary tract infections will be recorded on the case report form.

    Time frame: During the post operation day to 7 days after operation day,

07

Study locations

1 site
  • Kyung Hee University Hospital at Gangdong
    Seoul, 05278, Korea, Republic of
08

References and documents

Publications

  • Cho SY, Yang SB, Shin HS, Lee SH, Koh JS, Kwon S, Jung WS, Moon SK, Park JM, Ko CN, Park SU. Anti-inflammatory and immune regulatory effects of acupuncture after craniotomy: study protocol for a parallel-group randomized controlled trial. Trials. 2017 Jan 10;18(1):10. doi: 10.1186/s13063-016-1712-7. Erratum In: Trials. 2017 Oct 16;18(1):481. doi: 10.1186/s13063-017-2230-y. PubMed 28069040 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02761096
Lead sponsor
Kyunghee University Medical Center
Collaborators
Kyunghee University
Responsible party
Seong-Uk Park (KMD, PhD, Kyunghee University Medical Center) — Principal investigator
First posted
May 4, 2016
Start date
Apr 2016
Primary completion
May 2017
Completion
Nov 2017
Last update
Feb 28, 2019

Study contacts

Seong-Uk Park, KMD, PhD
principal investigator · Kyung Hee University Hospital at Gangdong

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion